1
Denosumab for Smoldering Multiple Myeloma
Condition(s):Smoldering Multiple MyelomaLast Updated:February 15, 2023Active, not recruiting
Smoldering Multiple Myeloma: 113 Clinical Trials, Page 1 of 12
Hide Studies Not Open or Pending
2
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Condition(s):Smoldering Multiple MyelomaLast Updated:September 7, 2023Recruiting
3
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
Condition(s):Smoldering Multiple MyelomaLast Updated:August 1, 2023Active, not recruiting
4
Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients
Condition(s):High Risk Smoldering Multiple MyelomaLast Updated:December 16, 2020Terminated
5
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma
Condition(s):Smoldering Multiple MyelomaLast Updated:June 13, 2023Completed
6
Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma
Condition(s):Smoldering Multiple MyelomaLast Updated:May 9, 2014Completed
7
E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Condition(s):Smoldering Myeloma; Smoldering Multiple MyelomaLast Updated:June 9, 2023Completed
8
PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma
Condition(s):Smoldering Multiple MyelomaLast Updated:April 15, 2022Terminated
9
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
Condition(s):Monoclonal Gammopathy; Smoldering Multiple MyelomaLast Updated:August 1, 2023Active, not recruiting
10
A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma
Condition(s):Smoldering Multiple Myeloma (SMM)Last Updated:July 21, 2023Not yet recruiting